Sfoglia per Rivista HAEMATOLOGICA
IN VITRO CULTURE OF BM CELLS OF MDS PATIENTS AND CYTC POLYMORPHISMS CAN PREDICT THE IN VIVO HEMATOLOGICAL RESPONSE OBSERVED DURING IRON CHELATION THERAPY WITH DEFERASIROX
2015-01-01 Cilloni, Daniela; Podestà, Marina; Cossu, C.; Calabrese, C.; Sabatini, F.; Del Corso, L.; Niscola, Pasquale; Crugnola, M.; Poloni, Antonella; Voso, Maria Teresa; Pelizzari, Susanna Fenu Anna Maria; Salvi, Flavia; Gioia, Daniela; Masiera, Elisa; Balleari, Enrico; Saglio, Giuseppe; Frassoni, Francesco
IRON-CHELATING THERAPY WITH DEFERASIROX IN HIGHER RISK MYELODYSPLASTIC SYNDROMES: A RETROSPECTIVE, MULTICENTER, ITALIAN STUDY
2014-01-01 P., Musto1; *, ; L., Maurillo2; V., Simeon3; Poloni, Antonella; C., Finelli5; C., Clissa5; E., Balleari6; A., Ricco7; Am, D’Arco8; A., Cortelezzi9; G., Tarantini10; O., Villani11; G., Mansueto11; C., Criscuolo11; M., Breccia12; P., Niscola13; A., Sanna14; F., Autore15; Mt, Voso15; S., Fenu16; A., Venditti2; V., Santini14; A., Levis17
LA POSITIVITÀ DEL WT1 POST-INDUZIONE È UN IMPORTANTE FATTORE PROGNOSTICO PREDITTIVO DI RECIDIVA PRECOCE IN UNA CASISTICA DI 80 PAZIENTI AFFETTI DA LEUCEMIA ACUTA MIELOIDE
2014-01-01 Capelli, D; Attolico, I; Saraceni, Francesco; Mancini, Stefania; Scortechini, Ar; Poloni, Antonella; Bartocci, C; Viola, N; Pascale, S; Nuccorini, R; Chiarucci, Martina; Serrani, F; Pizzuti, M; Leoni, Pietro; Olivieri, Attilio
Long-term results of reduced-intensity conditioning followed by allogeneic transplantation in relapsed lymphomas
2009-01-01 Corradini, P.; Dodero, A.; Farina, L.; Fanin, R.; Patriarca, F.; Miceli, R.; Matteucci, P.; Scime, R.; Narni, F.; Dalto, S.; Carniti, C.; Bacigalupo, A.; Bonifazi, F.; Olivieri, Attilio; Tarella, C.
LOW RPS14 EXPRESSION IN THE NON 5Q- MYELODYSPLASTIC SYNDROMES
2015-01-01 S., Grassi1; E., Ciabatti1; M., Rousseau2; F., Guerrini1; N., Cecconi1; G., Cervetti1; P., Musto3; F., La Rocca4; D., Cilloni5; V., Gaidano5; I., Petrini6; Poloni, Antonella; G. A., Palumbo8; S., Galimberti1; *,
LOW RPS14 EXPRESSION IS FREQUENTLY FOUND IN NON 5Q- MYELODYSPLASTIC SYNDROMES
2015-01-01 Galimberti, S; Ciabatti E: Rousseau M: Guerrini, F; Cecconi, N; Cervetti, G; Musto, P; La Rocca, F; Cilloni, D; Gaidano, V; Petrini, I; Poloni, Antonella; Palumbo, Ga; Grassi, S.
MECHANISM OF RESISTANCE TO DECITABINE IN CHRONIC MYELOMONOCYTIC LEUKEMIA
2014-01-01 Rossi A, Valencia A; Meldi K, Buchi F; Poloni, Antonella
‘MEMORIAL’ PLUS AMIFOSTINE EFFICACY AND FEASIBILITY IN AN ELDERLY COHORT OF 149 AML PATIENTS
2014-01-01 Capelli, D; Chiarucci, M; Saraceni, F; Poloni, Antonella; Mancini, G; Trappolini, S; Offidani, M; Rupoli, S; Montanari, M; Scortechini, Ar; Gini, G; Scortechini, I; Discepoli, G; Leoni, P; Olivieri, A.
MGA GUIDED INTENSIVE INDUCTION WITH HIGH DOSE CYTARABINE PLUS IDARUBICIN IN 149 AML ELDERLY PATIENTS
2015-01-01 D., Capelli; F., Saraceni; M., Chiarucci; Poloni, Antonella; G., Discepoli; Leoni, Pietro; Olivieri, Attilio
MOLECULAR PREDICTORS OF RESPONSE TO DECITABINE IN CHRONIC MYELOMONOCYTIC LEUKEMIA
2014-01-01 Rossi, A; 1 Valencia, A; 1 Abdel Wahab, O; 2 Figueroa, Me; 3 Tingting, Q; 3 Meldi, K; 3 Buchi, F; 1 Masala, E; 1 Sanna, A; 1 Allione, B; 4 Lunghi, M; Poloni, Antonella; 6 Angelucci, E; 7 Finelli, C; 8 Levis, A; 9 Santini, V1
MONITORING STRATEGY OF ANTHRACYCLINES CARDOTOXICITIES BY BIOMARKERS AND ECOCARDIOGRAPHY IN 104 PRESPECTIVES PATIENTS AFFECTED BY LYMPHOMA
2015-01-01 G. Gini, J. Olivieri; C., Bocci; S., Cacciagiù; M., Sampaolo; S., Trappolini; Olivieri, Attilio; M., Offidani; S., Rupoli; Poloni, Antonella; D., Capelli; M., Montanari; I., Scortechini; G. P., Perna; Leoni, Pietro
OVEREXPRESSION OF CDKN2B IS ASSOCIATED WITH REDUCED PROLIFERATIVE POTENTIAL IN MESENCHYMAL STEM CELL FROM HIGH-RISK MYELODYSPLASTIC SYNDROME
2014-01-01 Mattiucci, Domenico; Maurizi, G; Amatori, S; Costantini, B; Mariani, M; Mancini, Stefania; Fanelli, M; Olivieri, Attilio; Leoni, Pietro; Poloni, Antonella
Perturbed hematopoiesis in individuals with germline DNMT3A overgrowth Tatton-Brown-Rahman syndrome
2021-01-01 Tovy, Ayala; Rosas, Carina; Gaikwad, Amos S; Medrano, Geraldo; Zhang, Linda; Reyes, Jaime M; Huang, Yung-Hsin; Arakawa, Tastuhiko; Kurtz, Kristen; Conneely, Shannon E; Guzman, Anna G; Aguilar, Rogelio; Gao, Anne; Chen, Chun-Wei; Kim, Jean J; Carter, Melissa T; Lasa-Aranzasti, Amaia; Valenzuela, Irene; Van Maldergem, Lionel; Brunetti, Lorenzo; Hicks, M John; Marcogliese, Andrea N; Goodell, Margaret A; Rau, Rachel E
Prognostic significance of Molecular Remission after PUVA plus IFNalpha in early stage Mycosis Fungoides.
2001-01-01 Goteri, Gaia; Guiducci, B; Rupoli, S; Barulli, S; Brancorsini, D; Ranaldi, R; Bearzi, I; Giangiacomi, M; Cataldi, I; Serresi, S; GRILLI CICILIONI, E; Bugatti, L; Lanari, S; Offidani, Annamaria; Leoni, Pietro
QUALITY OF LIFE IN PATIENTS WITH LOWER RISK MYELODYSPLASTIC SYNDROMES WITH SEVERE THROMBOCYTOPENIA TREATED WITH ELTROMBOPAG: INTERIM RESULTS OF A RANDOMIZED, PLACEBOCONTROLLED PROSPECTIVE TRIAL
2015-01-01 E. N., Oliva1; * V., Santini2; C., Alati1; G., Sanpaolo3; Poloni, Antonella; A., Molteni5; F., Ronco1; G., Palumbo6; A., Marino1; S., Impera7; E., Balleari8; P., Salutari9; P., Cufari1; I., Santacaterina1; P., Avanzini10; P., Niscola11; A. M., Liberati12; A., Ricco13; F., Morabito14; A., Cortelezzi15; L., Fianchi16; F., Buccisano17; P., Fenaux18; O., Beyne Rauzy19; F., Rodeghiero20; F., Salvi21; R., Latagliata22
Reduced frequencies and functional impairment of dendritic cell subsets and non-classical monocytes in myelodysplastic syndromes
2021-01-01 Van Leeuwen-Kerkhoff, Nathalie; Westers, Theresia M; Poddighe, Pino J; Povoleri, Giovanni A M; Timms, Jessica A; Kordasti, Shahram; De Gruijl, Tanja D; Van de Loosdrecht, Arjan A
TARGETED SEQUENCING ANALYSIS OF COMMONLY MUTATED GENES IN CHRONIC MYELOMONOCYTIC LEUKEMIA USING NGS: IMPACT AND CLINICAL IMPLICATIONS
2015-01-01 Valencia, A; Abdel Wahab, O; Buchi, F; Masala, E; Sanna, A; Gozzini, A; Figueroa, Me; Contini, E; Torricelli, F; B., Allione B; Lunghi, M; Onida, F; Poloni, Antonella; Angelucci, E; Finelli, C; Levis, A; Gioia, D; Bosi, A; Santini, V.
TREATMENT WITH AZACITIDINE REVERSES MESENCHYMAL STEM CELLS DERIVED FROM HIGH RISK MYELODYSPLASTIC PATIENTS TO A NORMAL PHENOTYPE
2015-01-01 Poloni, Antonella; Maurizi, Giulia; Mattiucci, Domenico; Mancini, Stefania; Olivieri, Attilio; Leoni, Pietro
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
IN VITRO CULTURE OF BM CELLS OF MDS PATIENTS AND CYTC POLYMORPHISMS CAN PREDICT THE IN VIVO HEMATOLOGICAL RESPONSE OBSERVED DURING IRON CHELATION THERAPY WITH DEFERASIROX | 1-gen-2015 | Cilloni, Daniela; Podestà, Marina; Cossu, C.; Calabrese, C.; Sabatini, F.; Del Corso, L.; Niscola, Pasquale; Crugnola, M.; Poloni, Antonella; Voso, Maria Teresa; Pelizzari, Susanna Fenu Anna Maria; Salvi, Flavia; Gioia, Daniela; Masiera, Elisa; Balleari, Enrico; Saglio, Giuseppe; Frassoni, Francesco | |
IRON-CHELATING THERAPY WITH DEFERASIROX IN HIGHER RISK MYELODYSPLASTIC SYNDROMES: A RETROSPECTIVE, MULTICENTER, ITALIAN STUDY | 1-gen-2014 | P., Musto1; *, ; L., Maurillo2; V., Simeon3; Poloni, Antonella; C., Finelli5; C., Clissa5; E., Balleari6; A., Ricco7; Am, D’Arco8; A., Cortelezzi9; G., Tarantini10; O., Villani11; G., Mansueto11; C., Criscuolo11; M., Breccia12; P., Niscola13; A., Sanna14; F., Autore15; Mt, Voso15; S., Fenu16; A., Venditti2; V., Santini14; A., Levis17 | |
LA POSITIVITÀ DEL WT1 POST-INDUZIONE È UN IMPORTANTE FATTORE PROGNOSTICO PREDITTIVO DI RECIDIVA PRECOCE IN UNA CASISTICA DI 80 PAZIENTI AFFETTI DA LEUCEMIA ACUTA MIELOIDE | 1-gen-2014 | Capelli, D; Attolico, I; Saraceni, Francesco; Mancini, Stefania; Scortechini, Ar; Poloni, Antonella; Bartocci, C; Viola, N; Pascale, S; Nuccorini, R; Chiarucci, Martina; Serrani, F; Pizzuti, M; Leoni, Pietro; Olivieri, Attilio | |
Long-term results of reduced-intensity conditioning followed by allogeneic transplantation in relapsed lymphomas | 1-gen-2009 | Corradini, P.; Dodero, A.; Farina, L.; Fanin, R.; Patriarca, F.; Miceli, R.; Matteucci, P.; Scime, R.; Narni, F.; Dalto, S.; Carniti, C.; Bacigalupo, A.; Bonifazi, F.; Olivieri, Attilio; Tarella, C. | |
LOW RPS14 EXPRESSION IN THE NON 5Q- MYELODYSPLASTIC SYNDROMES | 1-gen-2015 | S., Grassi1; E., Ciabatti1; M., Rousseau2; F., Guerrini1; N., Cecconi1; G., Cervetti1; P., Musto3; F., La Rocca4; D., Cilloni5; V., Gaidano5; I., Petrini6; Poloni, Antonella; G. A., Palumbo8; S., Galimberti1; *, | |
LOW RPS14 EXPRESSION IS FREQUENTLY FOUND IN NON 5Q- MYELODYSPLASTIC SYNDROMES | 1-gen-2015 | Galimberti, S; Ciabatti E: Rousseau M: Guerrini, F; Cecconi, N; Cervetti, G; Musto, P; La Rocca, F; Cilloni, D; Gaidano, V; Petrini, I; Poloni, Antonella; Palumbo, Ga; Grassi, S. | |
MECHANISM OF RESISTANCE TO DECITABINE IN CHRONIC MYELOMONOCYTIC LEUKEMIA | 1-gen-2014 | Rossi A, Valencia A; Meldi K, Buchi F; Poloni, Antonella | |
‘MEMORIAL’ PLUS AMIFOSTINE EFFICACY AND FEASIBILITY IN AN ELDERLY COHORT OF 149 AML PATIENTS | 1-gen-2014 | Capelli, D; Chiarucci, M; Saraceni, F; Poloni, Antonella; Mancini, G; Trappolini, S; Offidani, M; Rupoli, S; Montanari, M; Scortechini, Ar; Gini, G; Scortechini, I; Discepoli, G; Leoni, P; Olivieri, A. | |
MGA GUIDED INTENSIVE INDUCTION WITH HIGH DOSE CYTARABINE PLUS IDARUBICIN IN 149 AML ELDERLY PATIENTS | 1-gen-2015 | D., Capelli; F., Saraceni; M., Chiarucci; Poloni, Antonella; G., Discepoli; Leoni, Pietro; Olivieri, Attilio | |
MOLECULAR PREDICTORS OF RESPONSE TO DECITABINE IN CHRONIC MYELOMONOCYTIC LEUKEMIA | 1-gen-2014 | Rossi, A; 1 Valencia, A; 1 Abdel Wahab, O; 2 Figueroa, Me; 3 Tingting, Q; 3 Meldi, K; 3 Buchi, F; 1 Masala, E; 1 Sanna, A; 1 Allione, B; 4 Lunghi, M; Poloni, Antonella; 6 Angelucci, E; 7 Finelli, C; 8 Levis, A; 9 Santini, V1 | |
MONITORING STRATEGY OF ANTHRACYCLINES CARDOTOXICITIES BY BIOMARKERS AND ECOCARDIOGRAPHY IN 104 PRESPECTIVES PATIENTS AFFECTED BY LYMPHOMA | 1-gen-2015 | G. Gini, J. Olivieri; C., Bocci; S., Cacciagiù; M., Sampaolo; S., Trappolini; Olivieri, Attilio; M., Offidani; S., Rupoli; Poloni, Antonella; D., Capelli; M., Montanari; I., Scortechini; G. P., Perna; Leoni, Pietro | |
OVEREXPRESSION OF CDKN2B IS ASSOCIATED WITH REDUCED PROLIFERATIVE POTENTIAL IN MESENCHYMAL STEM CELL FROM HIGH-RISK MYELODYSPLASTIC SYNDROME | 1-gen-2014 | Mattiucci, Domenico; Maurizi, G; Amatori, S; Costantini, B; Mariani, M; Mancini, Stefania; Fanelli, M; Olivieri, Attilio; Leoni, Pietro; Poloni, Antonella | |
Perturbed hematopoiesis in individuals with germline DNMT3A overgrowth Tatton-Brown-Rahman syndrome | 1-gen-2021 | Tovy, Ayala; Rosas, Carina; Gaikwad, Amos S; Medrano, Geraldo; Zhang, Linda; Reyes, Jaime M; Huang, Yung-Hsin; Arakawa, Tastuhiko; Kurtz, Kristen; Conneely, Shannon E; Guzman, Anna G; Aguilar, Rogelio; Gao, Anne; Chen, Chun-Wei; Kim, Jean J; Carter, Melissa T; Lasa-Aranzasti, Amaia; Valenzuela, Irene; Van Maldergem, Lionel; Brunetti, Lorenzo; Hicks, M John; Marcogliese, Andrea N; Goodell, Margaret A; Rau, Rachel E | |
Prognostic significance of Molecular Remission after PUVA plus IFNalpha in early stage Mycosis Fungoides. | 1-gen-2001 | Goteri, Gaia; Guiducci, B; Rupoli, S; Barulli, S; Brancorsini, D; Ranaldi, R; Bearzi, I; Giangiacomi, M; Cataldi, I; Serresi, S; GRILLI CICILIONI, E; Bugatti, L; Lanari, S; Offidani, Annamaria; Leoni, Pietro | |
QUALITY OF LIFE IN PATIENTS WITH LOWER RISK MYELODYSPLASTIC SYNDROMES WITH SEVERE THROMBOCYTOPENIA TREATED WITH ELTROMBOPAG: INTERIM RESULTS OF A RANDOMIZED, PLACEBOCONTROLLED PROSPECTIVE TRIAL | 1-gen-2015 | E. N., Oliva1; * V., Santini2; C., Alati1; G., Sanpaolo3; Poloni, Antonella; A., Molteni5; F., Ronco1; G., Palumbo6; A., Marino1; S., Impera7; E., Balleari8; P., Salutari9; P., Cufari1; I., Santacaterina1; P., Avanzini10; P., Niscola11; A. M., Liberati12; A., Ricco13; F., Morabito14; A., Cortelezzi15; L., Fianchi16; F., Buccisano17; P., Fenaux18; O., Beyne Rauzy19; F., Rodeghiero20; F., Salvi21; R., Latagliata22 | |
Reduced frequencies and functional impairment of dendritic cell subsets and non-classical monocytes in myelodysplastic syndromes | 1-gen-2021 | Van Leeuwen-Kerkhoff, Nathalie; Westers, Theresia M; Poddighe, Pino J; Povoleri, Giovanni A M; Timms, Jessica A; Kordasti, Shahram; De Gruijl, Tanja D; Van de Loosdrecht, Arjan A | |
TARGETED SEQUENCING ANALYSIS OF COMMONLY MUTATED GENES IN CHRONIC MYELOMONOCYTIC LEUKEMIA USING NGS: IMPACT AND CLINICAL IMPLICATIONS | 1-gen-2015 | Valencia, A; Abdel Wahab, O; Buchi, F; Masala, E; Sanna, A; Gozzini, A; Figueroa, Me; Contini, E; Torricelli, F; B., Allione B; Lunghi, M; Onida, F; Poloni, Antonella; Angelucci, E; Finelli, C; Levis, A; Gioia, D; Bosi, A; Santini, V. | |
TREATMENT WITH AZACITIDINE REVERSES MESENCHYMAL STEM CELLS DERIVED FROM HIGH RISK MYELODYSPLASTIC PATIENTS TO A NORMAL PHENOTYPE | 1-gen-2015 | Poloni, Antonella; Maurizi, Giulia; Mattiucci, Domenico; Mancini, Stefania; Olivieri, Attilio; Leoni, Pietro |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile